INTRODUCTION
sid proteins are critical for neurovirulence (reviewed in Roos and Casteel, 1992 ). Theiler's murine encephalomyelitis virus (TMEV) desAn impetus for the present investigations were the ignates a group of closely related strains of a picornaviapparently conflicting results from two laboratories workrus that cause enteric and central nervous system (CNS) ing with separately prepared recombinant viruses that disease in weanling mice (reviewed in Roos and Casteel, had the GDVII IB-2A genomic coding region substituted 1992). DA strain and other members of the TO subgroup for the corresponding part of DA (Jarousse et al., 1994) . cause a biphasic disease, initially infecting neurons and
The recombinant viruses used had been constructed then inducing a persistent, demyelinating infection of the from different parental DA and GDVII cDNA clones (Fu CNS (Lipton, 1975; Lipton and Dal Canto, 1978) . The latter et al., 1990; McAllister et al., 1989; Roos et al., 1989 ; disease serves as an experimental model of multiple Tangy et al., 1989) . Inoculation with GDIB-2A/DAFL3 virus sclerosis (MS). In contrast, inoculation of weaning mice (the name for the recombinant virus produced by the with GDVII strain and other members of the GDVII sublaboratory of Roos and colleagues) induced a persistent group leads to an acute, fatal polioencephalomyelitis infection with demyelination ( Fig. 1 ) (Jarousse et al., (Roos and Casteel, 1992) . 1994). In contrast, inoculation with TMR4 virus (the name To identify viral genes responsible for the different for a presumed identical recombinant virus produced by phenotypes, investigators have generated full-length inthe laboratory of Brahic and colleagues) neither persisted fectious cDNA clones of both DA and GDVII and then nor induced demyelination ( Fig. 1 ) (Tangy et al., 1991) . constructed chimeric cDNA clones with parts of DA and Sequencing of these and additional recombinant viruses GDVII exchanged for one another. The resultant recombigenerated from reagents interchanged between the two nant viruses have been inoculated into animals to elucilaboratories resolved the apparent conflict and demondate the molecular determinants of neurovirulence, destrated that the presence of an Asn at DA VP2 141 (in myelinating activity, and persistence (Pritchard et al., TMR4 virus) rather then a Lys (in the GD1B-2A/DAFL3 1993; Tangy et al., 1991; Zhang et al., 1993) . These studvirus) dramatically attenuated the ability of these recomies have demonstrated, for example, that the GDVII capbinant viruses to demyelinate and persist ( Fig. 1 ) (Jarousse et al., 1994) . Further studies showed that the parental DA virus of Roos and colleagues, DAFL3, had
Wild-type and mutant TMEV and their phenotypes. Segments derived from the pDAFL3 parental infectious clone (Roos et al., 1989a) are shown as open bars; segments derived from the pTMDA parental infectious clone (McAllister et al., 1989) are shown as shaded bars; segments derived from the pGDVII infectious clone (Fu et al., 1990) are shown as black bars. The TMEV genome organization is shown at the bottom: the 5UTR and 3UTR represent the 5 and 3 untranslated regions, respectively; L encodes the leader protein; P1 encodes the precursor for capsid proteins 1A (VP4), 1B (VP2), 1C (VP3), and 1D (VP1); P2 and P3 encode the precursors for nonstructural proteins. The circle shows the presence of a Lys (open) or Asn (shaded) as VP2 141 for the topmost 5 viruses; the bottom five viruses all have a Lys as VP2 141 (since they have a DAFL3 backbone), but have a mutant residue elsewhere in VP2 which is specified and shown as a speckled circle. The sensitivity (/) or resistance (0) of the particular virus to neutralization by DAmAb1 is noted; also see Table 1 and the Results section. The ability of these viruses to induce white matter pathology (meningitis, inflammation, and demyelination) is scored from / to /// as described under Materials and Methods and derived from the mean value (see Table 4 ). The approximate white matter pathology grades of TMDA, GD1B-2A/DAFL3, and TMR4 viruses are taken from a previous publication (Jarousse et al., 1994) . ND Å not determined.
et al., 1994) ; it remained unclear, however, whether the surrounding amino acids in the TO subgroup disease phenotype. presence of Asn as VP2 141 affected the ability of the parental DA strain (as well as the recombinant TMR4
The crystallographic three-dimensional structures of two members of the TO subgroup, DA and BeAn, have virus) to demyelinate and persist. One of the goals of the present study was to clarify the role of VP2 141 and been solved (Grant et al., 1992; Luo et al., 1992) . The primer was annealed in a separate reaction to produce in virus neutralization-especially since a neutralization a different mutant plasmid. Double-stranded cDNAs were site in the ''EF loop'' has been identified in the case of then generated from these single stranded/annealed Mengo virus, a cardiovirus related to TMEV (Boege et primers and used to transform Supercompetent Escheal., 1991) . In the present study, we demonstrate that the richia coli cells (Stratagene, La Jolla, CA). The plasmids EF loop of VP2 contains epitopes for a previously dewere sequenced using the dsDNA sequencing kit scribed neutralizing monoclonal antibody, DAmAb1 (Ni-(GIBCO BRL, Gaithersburg, MD) to confirm the presence tayaphan et al., 1985) , and is important for the late demyeof the changes. linating white matter disease.
Preparation of DAmAb1 neutralization escape mutant MATERIALS AND METHODS viruses Cells TMEV mAbs were prepared and characterized as previously described (Nitayaphan et al., 1985) . A wild-type BHK-21 cells (baby hamster kidney cells) were ob-DA virus stock was plaque-purified three times before tained from American Type Culture Collection and used use in the generation of mutant viruses resistant to for transfection, plaque assays, and the growth of stock DAmAb1. Mutants were isolated by growing the virus virus.
with mAb on BHK-21 cells for 4-7 passages and then performing a plaque assay in which L cells were infected Construction of mutant plasmids with serial 10-fold dilution of the resistant virus and then The template for the construction of mutants was the full-length, infectious cDNA clone of DA strain known as pDAFL3 (Roos et al., 1989a) . pDAFL3 was made into a full-length, single stranded, uracil-containing template Biochemicals, Indianapolis, IN), which digests 3 to the terminus of the viral genomic cDNA construct. The cDNA was then transcribed with T7 RNA polymerase and the overlaid with a 1:1 mixture of 21 minimal essential medium (GIBCO BRL) and 1% agarose containing a final RNA product was transfected into BHK-21 cells, as previously published (Roos et al., 1989a) . The resultant virus concentration of 10% DAmAb1, as previously described (Ohara et al., 1988) . The putative mutant virus was was plaque-purified twice and passed an additional two times in BHK-21 cells to produce a virus stock. The passed in BHK-21 cells until the titer was sufficiently high to carry out the required assays. RNA was extracted with DAFL3 virus stock used in the present study was a wildtype virus generated from transfection of transcripts deRNAzol (Biotecx, Houston, TX) and cDNA encoding VP2 was prepared by reverse transcription-polymerase chain rived from pDAFL3. To confirm the presence of the mutation in the virus, RNA was extracted using RNAzol (Bioreaction (RT-PCR) using the following primers: 5-AAT-GCTTTTGCTACTATG and 3-AGTTGCGGGCAACAGtecx) and cDNA, prepared by RT-PCR, was analyzed by an GIBCO BRL dsDNA cycle sequencing kit. CAG. The nucleotide sequence encoding all of VP2 was Neutralization assay 1% agarose and 5% fetal bovine serum in modified Eagle medium (GIBCO BRL) and incubated for 4-6 days at Plaque-reduction neutralization tests were performed 33Њ. After fixation and staining, plaques were counted. as previously described (Nitayaphan et al., 1985; Neutralization was defined as a reduction in the number et al., 1989b) . Approximately 100 plaque forming units of plaques by greater than 50% of control. A neutralization (PFU) of parental or mutant virus were incubated for 1 escape mutant was defined as a virus that requires aphr at room temperature in an equal volume of various proximately 10
1.5
-fold more mAb to be neutralized than dilutions of ascites fluid or hybridoma supernatant conthe same amount of wild-type virus. taining the respective mAb or an irrelevant mAb that
Animal inoculation served as a negative control. The virus-antibody mixture was allowed to adsorb onto BHK-21 cells with rocking Weanling SJL/J mice (Jackson Laboratory, Bar Harbor, ME) were inoculated intracerebrally with 0.03 ml confor 1 hr at 33Њ. The cell monolayers were overlaid with   FIG. 3 -Continued taining 1 1 10 7 PFU/ml of virus except in the case of amplify the coding region of VP2 (5-AATGCTTTTGCT-ACTATG, 3-GGGGTTTACGGGCTGGAT). The conditions DAFL3 (1.5 1 10 7 PFU/ml) and DA-VP2-141(Asn) (4.0 1 10 8 PFU/ml) viruses. Mice were sacrificed at 1 and 6 of the RT-PCR were as previously described (Zhang et al., 1995) . To ensure that a similar amount of cDNA was weeks postinoculation (PI) and their brains and spinal cords were removed for virus assays or histopathology. generated in the RT reaction, PCR was performed on the same sample using hypoxanthine phosphoribosyl transQuantitative pathologic analysis in spinal cords ferase (HPRT)-specific primers (Reiner et al., 1993) .
Spinal cords from at least 8 mice from each group RESULTS inoculated 6 weeks previously with either wild-type or DA VP2 141 is part of a neutralization site mutant virus were fixed in 10% formalin and embedded in paraffin. Sections of spinal cord were stained with
To delineate the importance of VP2 141 as a neutralizahematoxylin and eosin. The pathological findings were tion site of DA virus, DAFL3 VP2 141 Lys was changed scored usually on at least five spinal cord sections from to Asn by site-directed mutagenesis, and the resultant each mouse as follows: ''0,'' no pathology; ''/,'' meningitis virus, DA-VP2-141 (Asn), was tested in a plaque-reducwith not more than one inflammatory infiltrate in the pation neutralization test. Several TMEV neutralizing mAbs renchyma examined and no disruption of the white matthat we have described (Nitayaphan et al., 1985) neutralter; ''//,'' moderate inflammation and white matter disized this mutant virus as efficiently as wild-type virus ruption (that is present in about half of the white matter (data not shown); however, as shown in Table 1 , DAmAb1 parenchyma examined); ''///,'' severe inflammation neutralized wild-type DAFL3 virus, but failed to neutralize and white matter disruption (that is present in about 75%
DA-VP2-141 (Asn) mutant virus; similar results were obof the white matter parenchyma examined). A mean tained with another mutant virus separately derived from score and standard deviation (SD) of the white matter a different pDA-VP2-141 (Asn) cDNA clone. These results disease was determined for each group of mice inocusuggested that VP2 141 is part of an epitope of DAmAb1. lated with wild-type or mutant virus by setting the grade of ''0'' through ''///'' equivalent to ''0'' through ''3.'' StatisDAmAb1 escape mutant viruses have changes in the tical comparisons were performed according to the VP2 EF loop Mann-Whitney U test. The spinal cords from one or two To further define the location of a neutralization site mice inoculated 6 weeks previously with wild-type or of DAmAb1 in the VP 2 EF loop, we sequenced the whole each of the mutant viruses were fixed in 4% paraformalcoding region for VP2 from five DA isolates that had been dehyde, embedded in Epon, and stained with toluidine grown in the presence of DAmAb1. We compared these blue.
sequences with the sequence from two wild-type viruses, DAPW and DAFL3 (Table 2) . DAPW, a wild-type virus Analysis of virus growth similar to the one used as the parent for the generation Viruses were tested for in vitro growth with one-step of the DAmAb1 escape mutant viruses, had evidence of growth curves. Viruses were adsorbed onto petri dishes nucleotides coding for both a Thr and Ala at VP2 148 of BHK-21 cells for 1 hr at a multiplicity of infection of and for both a Gly and Ser at VP2 162, suggesting a 10. The monolayers were washed and scraped at 3, 6, mixed population of virus; in contrast, DAFL3 virus had 9, and 14 hr after infection. Cells and supernatants were coding sequence for a Thr at VP2 148 and Gly at VP2 162. assayed for infectivity by means of a plaque assay on In comparison to DAFL3 virus, all five DAmAb1 escape BHK-21 cells. mutant viruses had changes of VP2 148 from Thr to Ala Viruses were tested for in vivo growth by assaying and of VP2 162 from Gly to Ser; we suspect that these virus infectivity in brains from three mice inoculated with differences from DAFL3 virus were not important in resiswild-type or each of the mutant viruses 1 week PI. The tance to DAmAb1 since they were also present in DAPW brain was homogenized into a 20% solution in Hank'svirus. When compared to DAPW and DAFL3 virus, four buffered saline solution and assayed by means of plaque of five of the mutant viruses had a change in VP2 143 assay.
from Gly to Asp, while the fifth mutant had a VP2 173 Thr to Phe change ( Table 2) . The importance of all of these Analysis of viral genome persistence mutations with respect to virus neutralization was tested, as described below. To investigate virus persistence, RNA was extracted from the spinal cords of two or three mice from each DAVP2 143 and DAVP2 173 are part of the DAmAb1 group inoculated with either wild-type or mutant virus 6 neutralization site weeks previously. An RT reaction was performed with a random hexamer primer (Promega, Madison, WI). The RT As noted above, there were differences in amino acids in the VP2 EF loop found in escape mutant viproducts were amplified by PCR with two primers that ruses resistant to DA virus when compared to one or both wild-type viruses. In order to clarify the importance of particular residues in the DA neutralization site, the nucleotide changes were separately intro- tative agarose gel shows amplified products using DA VP2-specific mutant viruses. These mutant viruses were then tested primers (above) and HPRT primers (below) for samples from mice inocin a neutralization test (Table 1) suggesting that both DAVP2-143 Gly and VP2-173 Thr in addition to VP2-141 (Lys) are part of a neutralizing site of DAmAb1. In contrast, both DA-VP2-148 (Ala)
None of 22 mice inoculated with DA-VP2-141 (Asn) and and DA-VP2-162 (Ser) were neutralized by DAmAb1, none of 8 mice inoculated with DA-VP2-173 (Phe) virus indicating that VP2-148 Thr/Ala and VP2-162 Gly/Ser had significant white matter pathology. Only occasional are not part of a neutralizing site of DAmAb1.
mice inoculated with these two mutant viruses had minimal meningitis or very infrequent small inflammatory cell Virus infectivity infiltrates of the parenchyma (Table 4 , Figs. 3b and 3c) . We compared the in vitro and in vivo infectivity of the The minimal white matter pathology seen following DAmutant viruses with wild-type virus. The plaque size of VP2-141 (Asn) virus infection was of special note since the wild-type and mutant viruses was similar in size and animals were inoculated with more than 10-fold more small. The in vitro one-step growth curves for all the PFU of this mutant virus than with the other viruses. mutants (Fig. 2) was equal to or enhanced compared to Similar results were obtained from an additional two the wild-type DAFL3 virus, except in the case of DA-VP2-other DA-VP2-141 (Asn) mutant viruses, derived from 141 (Asn) virus. In contrast to DAFL3 virus, DA-VP2-141 separate cDNA clones. (Asn) virus had a slightly decreased growth at 3 and 7
Data from Epon-embedded sections of spinal cords hr, a greater level of growth at 9 hr, and an equivalent was consistent with the above results. Mice inoculated level of growth at 12 hr (Fig. 2) ; these differences were with DAFL3 and DA-VP2-143 (Asn) viruses demonstrated not thought to represent any in vitro growth defect of the demyelination. Small areas of infiltrated macrophages mutant virus. One week PI, brains from mice inoculated and inflammatory cells from animals inoculated with DAwith the different viruses had a similar level of infectivity VP2-141 had evidence of some demyelination; however, (Table 3) . These results suggested that mutant viruses these areas were extremely infrequent. Two of two DAdid not have a specific defect in growth in vitro or in the VP2-173 (Phe)-inoculated mice failed to demonstrate any brain.
evidence of demyelination, presumably because these regions were so difficult to find. The role of DA-VP2-141 and the surrounding region in
The above findings were supported by studies with disease phenotype DAmAb1 escape mutant viruses. DAmAb1 escape mutant virus 5, which has VP2 173 (Phe) (as well as VP2-Wild-type and mutant DA viruses were inoculated intra-148 [Ala] and 162 [Ser]) failed to demonstrate any white cerebrally into 3-week-old SJL/J mice, and animals were matter disease at 6 weeks PI, while DAmAb1 escape sacrificed at 6 weeks PI (Fig. 1, Table 4 ). As expected, mutant viruses 1-4, which have VP2 143 (Asp) (as well as all but 1 of 15 mice infected with wild-type DAFL3 virus VP2 148 [Ala], and 162 [Ser]) demonstrated white matter had moderate -severe pathological changes (greater destruction and meningitis (data not shown). than or equal to 2), with white matter disruption and
In order to determine whether virus persisted we analymphocyte infiltration of the spinal cord (Fig. 3a , Table  lyzed spinal cords from inoculated animals for the pres-4). A similar white matter disease pathology was seen ence of viral genome by RT-PCR. Viral genome persisted in most of the animals inoculated with DA-VP2-143 (Asp), in the spinal cord of mice inoculated by DA-VP2-141 DA-VP2-148 (Ala), and DA-VP2-162 (Ser) viruses (Fig. 1, (Asn), DA-VP2-143 (Asp), DA-VP2-148 (Ala), DA-VP2-162 Table 4 ); the mean degree of pathology was lower for (Ser), (Fig. 4) ; and DA wild-type viruses, the presence of the first two mutants than that seen with wild-type virus the appropriate mutation in the viral genome-amplified or DA-VP2-162 (Ser) virus (Table 4) ; however, it was clear products was confirmed by sequencing studies. In conthat these mutant viruses were capable of producing trast, RNA extracted from the spinal cords of mice inocusignificant white matter disease. These results were in lated 6 weeks previously with DA-VP2-173 (Phe) virus marked contrast with those seen following inoculation with DA-VP2-141 (Asn) and DA-VP2-173 (Phe) viruses.
showed no evidence of viral genome. The absence of amplification was not related to the primers used for Although three DA residues are part of the DAmAb1 PCR since the same primers efficiently amplified tissue neutralizing site in the EF loop, they do not have a similar culture stocks of DA-VP2-173 (Phe) virus as well as brain role in determining disease phenotype. Mice inoculated tissue from mice infected 1 week previously with the with DA-VP2-143 (Asp) virus showed white matter patholmutant.
ogy with virus persistence similar to that seen in mice inoculated with wild-type virus. DA-VP2-173 (Phe) virus DISCUSSION neither persisted nor induced demyelination at 6 weeks PI. DA-VP2-141 (Asn) virus persisted in the spinal cord TMEV is of special interest to virologists because of for 6 weeks PI; however, this mutant virus induced signifiits unusual disease phenotype. TO subgroup strains, cantly less late white matter pathology than wild-type such as DA, persist in the CNS for the whole life of virus. The persistence of DA-VP2-141 (Asn) in the abthe mouse and appear to have a restricted infection in sence of significant white matter disease is surprising; glial cells and macrophages. In addition, DA-induced it may be that there is an insufficient amount of the virus demyelinating disease serves as an experimental to induce demyelination or that the virus is located in model of MS: both disease processes have a similar different neural cells than is the case with wild-type virus. white matter pathology, and the immune system ap-
The diversity and complexity of disease phenotype prepears to contribute to demyelination in both. A goal of sumably reflects the varied effects of the mutated amino our work is to identify TMEV disease determinants and acid residue on the three-dimensional structure of the to characterize the anti-TMEV immune response in orviral capsid. This variation of disease phenotype may be der to better understand the pathogenesis of TMEVresponsible for our finding that DA-VP2-143 (Asp) and induced disease, as well as MS.
DA-VP2-148 (Ala) viruses produce white matter pathology Previous investigations of DA virus mutants generated that is significant in degree, but attenuated compared to in the presence of various neutralizing mAbs have proven that seen with wild-type virus. Interestingly, the particular valuable in the identification of neutralizing sites on the amino acid residues that constitute poliovirus type 1 neuvirus as well as molecular determinants of TMEV-intralization antigenic site 1 (VP1 94-102 in the BC loop) duced disease. We now show that DA amino acid 141 also have a very variable effect on mouse neurovirulence Lys, 143 Gly, and 173 Thr in the VP2 EF loop are part of (Couderc et al., 1991) . a neutralization site. We also tested isolates of GDVII In contrast to DA-VP2-141 (Asn) virus, TMDA virus virus that were grown in the presence of GDVII mAb4 (which is derived from an infectious cDNA clone of DA141 and mAb6 (both of which share the same neutralizing by Brahic and colleagues (Jarousse et al., 1994) ) is resite on GDVII subgroup strains (Nitayaphan et al., 1985) ) ported to have demyelinating activity although it also has for the presence of a mutation in the EF loop (data not the critical Asn at VP2. Presumably, DA-VP2-141 (Asn) and shown). All three GDVII escape mutants that were tested TMDA have another sequence difference(s) that moduhad a change in wild-type GDVII VP2 142 from Ser to lates the demyelinating activity. This difference may reside Phe, suggesting that, like DAmAb1, GDVII mAb4/6 have in the 1B-2A segment, as suggested by the fact that the a neutralization site on the TMEV VP2 EF loop; however, demyelinating activity of GD1B-2A/DAFL3 recombinant vidifferent amino acid residues presumably confer TO or rus appears to be modulated by an interaction of this GDVII subgroup specificity on these mAbs. In the case segment with the VP2 141 amino acid residue. of poliovirus type 1, VP2 142 in the EF loop is similarly Our results are more readily interpreted in the context part of a neutralization site (and affects mouse neurovirulence) (Couderc et al., 1991) .
of the known three-dimensional structure of the DA virus FIG. 5 . Mutations found in DA escape mutant viruses resistant to neutralizing mAbs mapped onto the X-ray crystal structure of the capsid of DA strain. (A) Color-coded spheres mark the locations of the X-ray crystal structure of the TMEV capsid. The surface features of the virus are highlighted by coloring the trace in a continuous spectrum from dark blue (low radius) to white (high radius). Features at a radius below 135 Å disappear into the black background. The spheres represent amino acid residues that have been mutated to escape neutralization by TMEV mAbs. The colors of the labels define the color-coding of the spheres. The larger spheres mark sites where single amino acid substitutions have been shown to attenuate the ability of DA virus to persist and cause demyelination, while mutation at the sites marked by the smaller spheres do not (see text). Note that residue 268 of VP1 is not marked with a large sphere in this panel or in B because its precise location is unknown [since the C-terminus of VP1 (residues 257-274) is disordered and therefore not visible in X-ray structure]; for this reason, the last visible residue of VP1 (256) is marked instead. (B) Close-up stereo view shows the sites mutated in DA escape mutant viruses resistant to TMEV neutralizing mAbs in one of the 60 protomers comprising the capsid. The color coding of the spheres is as in A, with the larger spheres marking sites where individual amino acid substitutions can affect the ability of the virus to persist and demyelinate. Each site is highly exposed on the capsid surface. VP 101 is located in the second part of the CD loop of VP1. All of the VP2 residues are in the EF loop of VP2. VP2 141 is located at each point of the prominent star-shaped plateaus at the fivefold symmetry axes (A). Residues 143 and 148 of VP1 are also near the tips of the star. Residue 173 of VP2 and residue 101 of VP1 are located near each other at the edge of the plateau, overlooking the large depression (pit) spanning the twofold axis. Residue 162 of VP2 is located at a lower radius, about halfway down the slope connecting the bottom of the depression and the edge of the plateau.
